REQUEST A DEMO
Total
USD $0.00
Search more companies

Sukurs-Med Anyszek, Stobiecki sp. p. (Poland)

Main Activities: General Medical and Surgical Hospitals
Full name: Sukurs-Med Anyszek, Stobiecki sp. p. Profile Updated: December 31, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English & Polish Download a sample report

Sukurs-Med Anyszek, Stobiecki sp. p. is a company based in Poland, with its head office in Krakow. It operates in the General Medical and Surgical Hospitals industry. Sukurs-Med Anyszek, Stobiecki sp. p. was incorporated on February 02, 2004. There are currently 5 (2009) people employed by Sukurs-Med Anyszek, Stobiecki sp. p.. The latest financial highlights indicate a net sales revenue increase of 44.32% in 2021. A growth of 35.33% was recorded in its total assets. In, 2021, the company’s net profit margin increased by 0.24%.

Headquarters
Ul. Stoigniewa 13
Krakow; Malopolskie; Postal Code: 30-572

Contact Details: Purchase the Sukurs-Med Anyszek, Stobiecki sp. p. report to view the information.

Basic Information
Total Employees:
Purchase the Sukurs-Med Anyszek, Stobiecki sp. p. report to view the information.
Outstanding Shares:
Purchase the Sukurs-Med Anyszek, Stobiecki sp. p. report to view the information.
Incorporation Date:
February 02, 2004
Key Executives
Purchase this report to view the information.
Partner
Purchase this report to view the information.
Partner
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Sukurs-Med Anyszek, Stobiecki sp. p. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
44.32%
Total operating revenue
44.33%
Operating profit (EBIT)
63.49%
Net Profit (Loss) for the Period
63.49%
Total assets
35.33%
Total equity
56.73%
Operating Profit Margin (ROS)
0.24%
Net Profit Margin
0.24%
Return on Equity (ROE)
3.86%
Quick Ratio
0.04%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?